Prevalence of antibodies associated with herd immunity: A new indicator to evaluate the establishment of herd immunity and to decide immunization strategies

Medical Decision Making

Volumn 30, Issue 4, 2010, Pages 438-443

  Plans, Pedro ^a  

^a Directorate of Public Health   (Spain)

Author keywords

DTaP vaccine; herd immunity; measles; MMR vaccine; mumps; pertussis; rubella; serological surveys; vaccination programs; varicella; varicella vaccine

Indexed keywords

ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CHILD; COMMUNICABLE DISEASE; DISEASE TRANSMISSION; EPIDEMIOLOGY; HERD IMMUNITY; HUMAN; IMMUNIZATION; IMMUNOLOGY;

ADOLESCENT; ADULT; ANTIBODIES; CHILD; COMMUNICABLE DISEASES; HUMANS; IMMUNITY, HERD; IMMUNIZATION; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 77954923596     PISSN: 0272989X     EISSN: 1552681X     Source Type: Journal    
DOI: 10.1177/0272989X09353453     Document Type: Article

References (16)

1. Anderson RM The concept of herd immunity and the design of community-based immunization programmes. Vaccine. 1992 ; 10: 928-935.
2. Anderson RM, May RM Infectious Diseases in Humans: Dynamics and Control. Oxford: Oxford University Press ; 1995.
3. Anderson RM, Hollingsworth TD, Nokes DJ Mathematical models of transmission and control. In: Detels R, Beaglehole R, Lansang MA, Gulliford M, eds. Oxford Textbook of Public Health. Vol. 2. New York: Oxford University Press ; 2009. p 715-744.
4. Lilienfeld AH, Lilienfeld DE Foundations of Epidemiology. New York: Oxford University Press ; 1980.
5. Centers for Disease Control (CDC). General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACID). MMWR. 2006 ; 55 (RR-13). 1-56.
6. Centers for Disease Control (CDC). Measles, mumps and rubella-vaccine use and strategies for elimination of measles, rubella and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACID). MMWR. 1998 ; 47 (RR-8). 1-57.
7. Centers for Disease Control (CDC). Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACID). MMWR. 1996 ; 45 (RR-11). 1-25.
8. Melker HE, Versteegh FGA, Conyn-van Spaendonck MAE, et al. Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis. J Clin Microbiol. 2000 ; 38: 800-806.
9. Watanabe M., Connella B., Weiss AA Characterization of serological response to pertussis. Cin Vac Immunol. 2006 ; 13: 341-348.
10. Plans-Rubió P. Critical prevalence of antibodies minimizing vaccination costs for hepatitis A, hepatitis B, varicella, measles and tetanus in adults and adolescents in Catalonia, Spain. Vaccine. 2004, 22: 4002-4013.
11. Arita I., Wickett J., Fenner F. Impact of population density on immunization programmes. J Hyg. 1986 ; 96: 459-466.
12. World Health Organization (WHO) Regional Office for Europe. Targets for Health for All. Copenhagen: WHO ; 1985.
13. Silman AJ, Allwright SPA. Elimination or Reduction of Diseases? Oxford: Oxford University Press ; 1988.
14. Hinman AR Eradication of vaccine-preventable diseases. Annual Rev Public Health. 1999 ; 20: 211-229.
15. Pebody RG, Gay NJ, Giammanco A., at al. The seroepidemiology of Bordetella pertussis in Western Europe. Epidemiol Infect. 2005 ; 133: 159-171.
16. Halperin SA Pertussis: a disease and vaccine for all ages. New Engl J Med. 2005 ; 353: 1615-1617.